Incidence and timing of common adverse events in Lenvatinib-treated patients from the SELECT trial and their association with survival outcomes

por Haddad, Robert I., Schlumberger, Martin, Wirth, Lori J., Sherman, Eric J., Shah, Manisha H., Robinson, Bruce, Dutcus, Corina E., Teng, Angela, Gianoukakis, Andrew G., Sherman, Steven I.
Publicado 2017

Phase I Study of the Liposomal Formulation of Eribulin (E7389-LF): Results from the Advanced Gastric Cancer Expansion Cohort

por Shitara, Kohei, Hirao, Motohiro, Iwasa, Satoru, Oshima, Takashi, Komatsu, Yoshito, Kawazoe, Akihito, Sato, Yasuyoshi, Hamakawa, Takuya, Yonemori, Kan, Machida, Nozomu, Yuki, Satoshi, Suzuki, Takuya, Okumura, Shiori, Takase, Takao, Semba, Taro, Zimmermann, Bob, Teng, Angela, Yamaguchi, Kensei
Publicado 2023